Search Results 2371-2380 of 14784 for Venlafaxine

  1. Biomarker and Drug Development - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies PINK1/PRKN (Parkin)-directed mitochondrial quality control.

  2. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...

  3. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    About this study. The purpose of the trial is to establish the tolerability of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors.

  4. Patient Stories - Raymund R. Razonable, M.D. - Mayo Clinic

    Raymund R. Razonable, M.D. · Infectious Disease Specialist · Vice Chair, Infectious Diseases, Minnesota.

  5. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  6. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

    The purpose of this study is to evaluate HPN217 as monotherapy to assess the safety, tolerability and pharmacokinetics in patients with relapsed/ refractory ...

  7. A Study to Analyze the Vaginal and Bladder Microbiome in Patients Undergoing Vaginal Estrogen or Vaginal LASER Therapy - Mayo Clinic

    About this study. The purpose of this study is to evaluate vaginal microbiome at baseline and at 3 months in menopausal women with either vaginal atrophy ...

  8. Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine - Mayo Clinic News Network

    "It is important for the public to know that COVID-19 is now a vaccine-preventable disease. The best way to avoid developing potential neurologic complications ...

  9. A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    This is a multi-center, open-label, Phase Ib dose escalation / Phase II study in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC) ...

  10. Publications - Terrence L. Trentman, M.D. - Mayo Clinic

    Trentman TL, Schwedt TJ. Occipital nerve stimulation and beyond: when is invasive peripheral stimulation for headaches appropriate? Expert Rev Neurother. 2016; ...